Market Value3,118,189,972
Total Holdings66
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JBIO / Jade Biosciences, Inc.
BBIO / BridgeBio Pharma, Inc.
GERN / Geron Corporation
OCUL / Ocular Therapeutix, Inc.
UPB / Upstream Bio, Inc.
PCVX / Vaxcyte, Inc.
CNTX / Context Therapeutics Inc.
RAPP / Rapport Therapeutics, Inc.
INO / Inovio Pharmaceuticals, Inc.
NRIX / Nurix Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc. Put
SRPT / Sarepta Therapeutics, Inc.
TECX / Tectonic Therapeutic, Inc.
NVAX / Novavax, Inc.
CYBN / Cybin Inc.
IVVD / Invivyd, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
RAPT / RAPT Therapeutics, Inc.
XNCR / Xencor, Inc.
MBX / MBX Biosciences, Inc.
AVTX / Avalo Therapeutics, Inc.
KRRO / Korro Bio, Inc.
ETNB / 89bio, Inc.
ALGS / Aligos Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
PTGX / Protagonist Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SYRE / Spyre Therapeutics, Inc.
CLYM / Climb Bio, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
INSM / Insmed Incorporated
SAGE / Sage Therapeutics, Inc.
AMGN / Amgen Inc.
RAPT / RAPT Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
ALLK / Allakos Inc.
RGLS / Regulus Therapeutics Inc.
EWTX / Edgewise Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
NGNE / Neurogene Inc.
ENGN / enGene Holdings Inc.
IMVT / Immunovant, Inc.
TERN / Terns Pharmaceuticals, Inc.
GHRS / GH Research PLC
ORKA / Oruka Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
MTSR / Metsera, Inc.
BCAX / Bicara Therapeutics Inc.
IKNA / Ikena Oncology, Inc.
MAZE / Maze Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
ANIP / ANI Pharmaceuticals, Inc.
GH / Guardant Health, Inc.
AXSM / Axsome Therapeutics, Inc.
OKUR / OnKure Therapeutics, Inc.
SEPN / Septerna, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
AKRO / Akero Therapeutics, Inc.
ZURA / Zura Bio Limited
IONS / Ionis Pharmaceuticals, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
PLRX / Pliant Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
20D0 / Cidara Therapeutics, Inc.
MRUS / Merus N.V.
DVAX / Dynavax Technologies Corporation
MNMD / Mind Medicine (MindMed) Inc.
CBIO / Crescent Biopharma, Inc.